Cargando…
Potential Therapeutic Applications of Synthetic Conotoxin s-cal14.2b, Derived from Californiconus californicus, for Treating Type 2 Diabetes
The FDA’s approval of peptide drugs such as Ziconotide or Exendin for pain relief and diabetes treatment, respectively, enhanced the interest to explore novel conotoxins from Conus species venom. In general, conotoxins can be used in pathologies where voltage-gated channels, membrane receptors, or l...
Autores principales: | Lugo-Fabres, Pavel H., Otero-Sastre, Leslie M., Bernáldez-Sarabia, Johanna, Camacho-Villegas, Tanya A., Sánchez-Campos, Noemi, Serrano-Bello, Janeth, Medina, Luis A., Muñiz-Hernández, Saé, de la Cruz, Lizbeth, Arenas, Isabel, Barajas-Martínez, Antonio, Garcia, David E., Nuñez-Garcia, Linda, González-Canudas, Jorge, Licea-Navarro, Alexei F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391312/ https://www.ncbi.nlm.nih.gov/pubmed/34440140 http://dx.doi.org/10.3390/biomedicines9080936 |
Ejemplares similares
-
The Diversified O-Superfamily in Californiconus californicus Presents a Conotoxin with Antimycobacterial Activity
por: Bernáldez-Sarabia, Johanna, et al.
Publicado: (2019) -
In Vitro Effect of the Synthetic cal14.1a Conotoxin, Derived from Conus californicus, on the Human Parasite Toxoplasma gondii
por: De León-Nava, Marco A., et al.
Publicado: (2016) -
Chimeric Peptides from Californiconus californicus and Heterodontus francisci with Antigen-Binding Capacity: A Conotoxin Scaffold to Create Non-Natural Antibodies (NoNaBodies)
por: Dueñas, Salvador, et al.
Publicado: (2023) -
Proapoptotic Index Evaluation of Two Synthetic Peptides Derived from the Coneshell Californiconus californicus in Lung Cancer Cell Line H1299
por: Oroz-Parra, Irasema, et al.
Publicado: (2019) -
Conotoxin Patenting Trends in Academia and Industry
por: Sanchez-Campos, Noemi, et al.
Publicado: (2022)